menu search

Allogene therapeutics announces three poster presentations from its next generation allocar t™ platform at the society for immunotherapy of cancer (sitc) annual meeting

Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T™ Cells Demonstration of Dagger™ Technolog...

September 27, 2023, 1:09 pm

Why immunovant stock is bolting higher today

Tuesday, immunovant announced early-stage trial results for an autoimmune disease candidate that caused...

September 27, 2023, 12:21 pm

Mink therapeutics to present data update from allogeneic inkt cells in solid tumors at sitc 2023

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discove...

September 27, 2023, 9:05 am

Crispr therapeutics to present at the society for immunotherapy of cancer (sitc) 38th annual meeting

ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating tr...

September 27, 2023, 9:01 am

immunovant: immune boost, from clinical trials to an aggressive bullish stock

Although immunovant's stock has rallied around 100% since January, recent data on its therapeutic candi...

September 27, 2023, 5:30 am

immunovant announces proposed offering of $300 million of common stock

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — immunovant, Inc. (Nasdaq: IMVT), a clinical-stage ...

September 26, 2023, 9:00 pm

Roivant stock could go higher on monetization potential of ‘blockbuster' assets

Roivant shares finished more than 20% higher on Tuesday after immunovant, in which Roivant holds a 56.5...

September 26, 2023, 4:59 pm

immunovant shares skyrocket after trial of its autoimmune drug beats expectations

immunovant (IMVT) shares virtually doubled on Tuesday after the biopharmaceutical company reported posi...

September 26, 2023, 4:20 pm

Why shares of immunovant are soaring on tuesday

immunovant reported positive phase 1 trial data for IMVT-1402. The company said the therapy showed a st...

September 26, 2023, 3:23 pm

Roivant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results

IMVT-1402 subcutaneous (SC) doses achieved peak immunoglobulin G (IgG) reductions that are similar to t...

September 26, 2023, 10:00 am

immunovant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results

IMVT-1402 subcutaneous (SC) doses achieved peak immunoglobulin G (IgG) reductions that are similar to t...

September 26, 2023, 10:00 am

immunovant and roivant jump as new drug shapes up to become blockbuster

There was a bumper boost for stock in two Nasdaq-listed biotechs premarket after an experimental antibody treatment was revealed to have blockbuster p...

September 26, 2023, 9:28 am

These 2 biotech stocks are bucking a down market tuesday

Markets moved lower on Tuesday, giving up some gains from Monday. immunovant released positive trial da...

September 26, 2023, 9:10 am

immunovant to host conference call and webcast to report initial imvt-1402 phase 1 results on september 26, 2023

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) — immunovant, Inc. (Nasdaq: IMVT), a clinical-stage ...

September 26, 2023, 3:01 am

immunovant to host conference call and webcast to report initial imvt-1402 phase 1 results on september 26, 2023

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- immunovant, Inc. (Nasdaq: IMVT), a clinical-stage ...

September 25, 2023, 11:01 pm

Pds biotech reschedules key opinion leader roundtable addressing current and future treatments for recurrent/metastatic hpv-positive hnscc and the potential application of pds0101

Event to be held on Tuesday, October 3 from 8:00 to 9:00 AM EDT PRINCETON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Na...

September 25, 2023, 12:00 pm

Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy

SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel ...

September 25, 2023, 9:30 am

immunomics stocks: 3 ways to play this massive ai-biotech megatrend

Biotech has long seemed to move slower than its fellow tech fields due to the complexity of biological systems and the difficulty of drug regulations....

September 22, 2023, 5:05 pm

Aim immunotech selected to present at the 3rd annual marie sklodowska-curie symposium on cancer research and care

OCALA, Fla., Sept. 22, 2023 (GLOBE NEWSWIRE) -- AIM immunoTech Inc. (NYSE American: AIM) (“AIM” or ...

September 22, 2023, 9:05 am

Drugmaker merck says keytruda combination fails in lung cancer trial

Merck said on Friday its cancer immunotherapy Keytruda in combination with partner Eisai's drug failed ...

September 22, 2023, 7:09 am


Search within

Pages Search Results: